1. Home
  2. SLNO vs KMPR Comparison

SLNO vs KMPR Comparison

Compare SLNO & KMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • KMPR
  • Stock Information
  • Founded
  • SLNO 1999
  • KMPR 1990
  • Country
  • SLNO United States
  • KMPR United States
  • Employees
  • SLNO N/A
  • KMPR N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KMPR Property-Casualty Insurers
  • Sector
  • SLNO Health Care
  • KMPR Finance
  • Exchange
  • SLNO Nasdaq
  • KMPR Nasdaq
  • Market Cap
  • SLNO 3.8B
  • KMPR 3.3B
  • IPO Year
  • SLNO 2014
  • KMPR N/A
  • Fundamental
  • Price
  • SLNO $65.46
  • KMPR $49.27
  • Analyst Decision
  • SLNO Strong Buy
  • KMPR Buy
  • Analyst Count
  • SLNO 9
  • KMPR 4
  • Target Price
  • SLNO $116.78
  • KMPR $67.50
  • AVG Volume (30 Days)
  • SLNO 1.7M
  • KMPR 1.1M
  • Earning Date
  • SLNO 11-05-2025
  • KMPR 11-05-2025
  • Dividend Yield
  • SLNO N/A
  • KMPR 2.60%
  • EPS Growth
  • SLNO N/A
  • KMPR 562.92
  • EPS
  • SLNO N/A
  • KMPR 5.31
  • Revenue
  • SLNO $32,656,999.00
  • KMPR $4,784,500,000.00
  • Revenue This Year
  • SLNO N/A
  • KMPR $0.77
  • Revenue Next Year
  • SLNO $182.29
  • KMPR $6.74
  • P/E Ratio
  • SLNO N/A
  • KMPR $9.27
  • Revenue Growth
  • SLNO N/A
  • KMPR 2.67
  • 52 Week Low
  • SLNO $41.50
  • KMPR $45.02
  • 52 Week High
  • SLNO $90.32
  • KMPR $73.01
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.66
  • KMPR 44.29
  • Support Level
  • SLNO $63.02
  • KMPR $45.55
  • Resistance Level
  • SLNO $72.88
  • KMPR $50.52
  • Average True Range (ATR)
  • SLNO 4.25
  • KMPR 1.27
  • MACD
  • SLNO 1.03
  • KMPR -0.07
  • Stochastic Oscillator
  • SLNO 56.61
  • KMPR 55.78

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About KMPR Kemper Corporation

Kemper Corp is a diversified insurance company that provides services in property and casualty insurance, along with life and health insurance. The company's property and casualty segment offers personal and commercial lines for home and automotive products. The company conducts its operations through two operating segments: Specialty Property & Casualty Insurance, and Life Insurance.

Share on Social Networks: